Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$632.3b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

AbbVie

Market Cap: US$442.4b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$335.5b

Operates as a healthcare company worldwide.

AstraZeneca

Market Cap: UK£183.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Amgen

Market Cap: US$226.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Bristol-Myers Squibb

Market Cap: US$132.0b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Chugai Pharmaceutical

Market Cap: JP¥11.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

CSL

Market Cap: AU$75.6b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥345.2b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Galderma Group

Market Cap: CHF 39.5b

Operates as a dermatology company worldwide.

Natera

Market Cap: US$45.3b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Teva Pharmaceutical Industries

Market Cap: US$42.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Haleon

Market Cap: UK£31.3b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

IQVIA Holdings

Market Cap: US$39.7b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Otsuka Holdings

Market Cap: JP¥6.3t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Sandoz Group

Market Cap: CHF 31.8b

Develops, manufactures, and markets generic and biosimilars worldwide.

Biogen

Market Cap: US$30.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

Daiichi Sankyo Company

Market Cap: JP¥4.9t

Manufactures and sells pharmaceutical products in Japan and internationally.

Illumina

Market Cap: US$28.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Astellas Pharma

Market Cap: JP¥4.1t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$199.4b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.

Hansoh Pharmaceutical Group

Market Cap: HK$199.3b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Innovent Biologics

Market Cap: HK$168.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Ipsen

Market Cap: €13.4b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.

Eurofins Scientific

Market Cap: €12.1b

Provides various analytical testing and laboratory services worldwide.

ICON

Market Cap: US$13.1b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Revvity

Market Cap: US$13.0b

Provides health sciences solutions, technologies, and services.

Arrowhead Pharmaceuticals

Market Cap: US$12.5b

Develops medicines for the treatment of intractable diseases in the United States.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.8b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Elanco Animal Health

Market Cap: US$11.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥77.7b

Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.

WuXi XDC Cayman

Market Cap: HK$88.5b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Dr. Reddy's Laboratories

Market Cap: ₹983.3b

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

CSPC Innovation Pharmaceutical

Market Cap: CN¥61.8b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

Avantor

Market Cap: US$9.1b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.